Orhan Sezgın

1.9k total citations
98 papers, 1.3k citations indexed

About

Orhan Sezgın is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Orhan Sezgın has authored 98 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Surgery, 36 papers in Epidemiology and 30 papers in Hepatology. Recurrent topics in Orhan Sezgın's work include Liver Disease Diagnosis and Treatment (23 papers), Hepatitis B Virus Studies (21 papers) and Hepatitis C virus research (20 papers). Orhan Sezgın is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Hepatitis B Virus Studies (21 papers) and Hepatitis C virus research (20 papers). Orhan Sezgın collaborates with scholars based in Türkiye, United States and United Kingdom. Orhan Sezgın's co-authors include Engin Altıntaşž, Enver Uçbılek, Gürol Emekdaş, Ülkü Sarıtaş, Burhan Şahın, Seda Tezcan, Mehmet Sami Serin, Eyüp Naci Tiftik, Gönül Aslan and Mahmut Ülger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Human Genetics.

In The Last Decade

Orhan Sezgın

94 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Orhan Sezgın Türkiye 17 537 271 247 237 209 98 1.3k
Hak Yang Kim South Korea 19 580 1.1× 596 2.2× 318 1.3× 236 1.0× 48 0.2× 58 1.3k
A. Amoruso Italy 24 663 1.2× 406 1.5× 205 0.8× 189 0.8× 119 0.6× 53 1.4k
Donal Maguire Ireland 21 841 1.6× 249 0.9× 218 0.9× 658 2.8× 91 0.4× 71 1.4k
A Geubel Belgium 19 561 1.0× 308 1.1× 352 1.4× 176 0.7× 101 0.5× 58 1.3k
Graziella Guariso Italy 24 1.3k 2.5× 977 3.6× 170 0.7× 171 0.7× 170 0.8× 86 2.4k
Erkin Öztaş Türkiye 18 439 0.8× 209 0.8× 103 0.4× 204 0.9× 68 0.3× 75 853
Raffaella Morotti United States 26 1.1k 2.0× 558 2.1× 354 1.4× 436 1.8× 270 1.3× 95 2.3k
Giovanni Terrosu Italy 22 1.1k 2.1× 292 1.1× 124 0.5× 486 2.1× 74 0.4× 109 1.6k
Jin Hong Kim South Korea 30 1.6k 2.9× 464 1.7× 315 1.3× 1.3k 5.7× 92 0.4× 140 2.4k
E Adám United States 17 490 0.9× 440 1.6× 41 0.2× 123 0.5× 136 0.7× 54 1.3k

Countries citing papers authored by Orhan Sezgın

Since Specialization
Citations

This map shows the geographic impact of Orhan Sezgın's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orhan Sezgın with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orhan Sezgın more than expected).

Fields of papers citing papers by Orhan Sezgın

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orhan Sezgın. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orhan Sezgın. The network helps show where Orhan Sezgın may publish in the future.

Co-authorship network of co-authors of Orhan Sezgın

This figure shows the co-authorship network connecting the top 25 collaborators of Orhan Sezgın. A scholar is included among the top collaborators of Orhan Sezgın based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orhan Sezgın. Orhan Sezgın is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sezgın, Orhan, et al.. (2025). The appropriate use of proton pump inhibitors: Single centre experience. 24(1). 35–40. 1 indexed citations
2.
Holland‐Fischer, Peter, Jesper Bach Hansen, Yusuf Yılmaz, et al.. (2025). Clinical and Biochemical Characteristics of a Danish and Turkish Cohort of Incident and Prevalent Patients with Primary Biliary Cholangitis. The Turkish Journal of Gastroenterology. 36(4). 241–246. 2 indexed citations
3.
Sezgın, Orhan, et al.. (2023). The Abdominal Ultrasonography Results of Cappadocia Cohort Study of Turkey Reveals High Prevalence of Fatty Liver. The Turkish Journal of Gastroenterology. 34(6). 652–664. 7 indexed citations
4.
Törüner, Murat, Metin Başaranoğlu, Özlen Atuğ, et al.. (2022). Improvement of Work Productivity and Quality of Life with Anti-Tumor Necrosis Factor Treatment Used in Crohn’s Disease in Routine Clinical Practice in Turkey. The Turkish Journal of Gastroenterology. 33(5). 406–413. 2 indexed citations
5.
Akarca, Ulus Salih, Belkıs Ünsal, Orhan Sezgın, et al.. (2021). Characteristics of Newly Diagnosed Hepatocellular Carcinoma Patients Across Turkey: Prospective Multicenter Observational 3K Registry Study. The Turkish Journal of Gastroenterology. 32(12). 1019–1028. 2 indexed citations
6.
Sezgın, Orhan, et al.. (2021). Efficacy and Safety of Percutaneous Endoscopic Gastrostomy in Elderly Patients Aged Over 65: A Tertiary Center Long-term Results. SHILAP Revista de lepidopterología. 59(2). 128–132. 1 indexed citations
7.
Uçbılek, Enver, et al.. (2021). Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients. Archives of Virology. 167(1). 153–161. 1 indexed citations
8.
Sezgın, Orhan, et al.. (2020). Foreign Bodies on the Path of Nutrition: Retrospective Evaluation of Our Clinical Experience. SHILAP Revista de lepidopterología. 58(1). 15–20. 1 indexed citations
10.
Sezgın, Orhan, et al.. (2019). Retrospective Evaluation of Corrosive Substance Ingestion: Single Center Experience. SHILAP Revista de lepidopterología. 20(5). 472–476. 2 indexed citations
12.
Serin, Mehmet Sami, Engin Kaplan, Aylin Döğen, et al.. (2014). Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Molecular Biology Reports. 42(3). 713–720. 73 indexed citations
13.
Tözün, Nurdan, Orhan Sezgın, Murat Gülşen, et al.. (2012). Safety of peginterferon alfa-2a (40KD) treatment in patients with chronic hepatitis B infection: An observational, multicenter, open label, non-interventional study in Turkish patients. The Turkish Journal of Gastroenterology. 23(5). 552–559. 1 indexed citations
14.
Sezgın, Orhan, et al.. (2012). Knowledge levels of general practitioners employed in Mersin province about hepatitis B and hepatitis C. DergiPark (Istanbul University). 2 indexed citations
15.
Sezgın, Orhan, Engin Altıntaşž, & Enver Uçbılek. (2010). Ectopic opening of the common bile duct into the stomach. The Turkish Journal of Gastroenterology. 21(2). 163–167. 5 indexed citations
16.
Sezgın, Orhan, et al.. (2010). Fasciola hepatica-induced acute pancreatitis: Report of two cases and review of the literature. The Turkish Journal of Gastroenterology. 21(2). 183–187. 16 indexed citations
17.
Emekdaş, Gürol, et al.. (2009). Seroepidemiology of Fasciola Hepatica in Mersin province and surrounding towns and the role of family history of the Fascioliasis in the transmission of the parasite. The Turkish Journal of Gastroenterology. 20(3). 198–203. 21 indexed citations
18.
19.
Tiftik, Naci, Ahmet Kıykım, Engin Altıntaşž, et al.. (2003). Therapeutic plasma exchange for multidrug intoxication: A case report. Journal of Clinical Apheresis. 18(3). 132–133. 6 indexed citations
20.
Altıparmak, Emin, Orhan Sezgın, Erkan Parlak, et al.. (2001). Colorectal polyps "The Yüksek İhtisas experience". 12(1). 49–52. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026